About the Product

Description


Ropinole 0.5 Tablet contains Ropinirole 0.5mg, a dopamine agonist used in the management of Parkinson’s disease and restless leg syndrome (RLS). It helps improve motor function by stimulating dopamine receptors in the brain, reducing symptoms such as tremors, muscle stiffness, slow movement, and leg discomfort during rest.

This medication is commonly used as monotherapy in early Parkinson’s or in combination therapy during advanced treatment stages. Its role in improving mobility and quality of life makes it a widely prescribed drug in neurological care.

Belonging to the neurology and CNS therapeutic segment, Ropinole 0.5 Tablet is frequently prescribed by neurologists and movement disorder specialists. Its chronic prescription nature ensures steady demand across hospitals, neurological centers, and pharmacy networks.

For PCD franchise owners, wholesalers, and export buyers, this product offers a profitable opportunity within the growing neuro segment. It is available for bulk orders, private-label third-party manufacturing, institutional supply, and export logistics support across India.

Common side effects include drowsiness, dizziness, weight gain, increased appetite, dry mouth, constipation, and sleep disturbances; less commonly patients may experience extrapyramidal symptoms (movement disorders), elevated prolactin levels, metabolic changes (weight/BG/lipids), or orthostatic dizziness — seek medical help for severe symptoms.

Risplom 4 Tablet is indicated for the treatment of schizophrenia, bipolar disorder (acute mania and maintenance), irritability associated with autism spectrum disorder, and behavioural disturbances related to psychosis; it helps reduce aggression, severe anxiety-driven behaviours, hallucinations, and disorganized thought.

Take Risplom 4 Tablet exactly as prescribed and do not stop it abruptly; inform your doctor about heart disease, diabetes, liver or kidney problems, a history of seizures, or pregnancy; avoid alcohol and activities requiring alertness until you know how it affects you; regular monitoring (weight, glucose, lipids, and movement symptoms) may be required.

Store Risplom 4 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Ropinirole 0.5mg Tablet in the PCD pharma franchise market?

Ropinirole 0.5mg Tablet has growing demand in the neurology, Parkinson’s disease management, and CNS (Central Nervous System) care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on neurological and specialty medicine portfolios.

Why should medical distributors include Ropinirole 0.5mg Tablet in their product range?

Medical distributors and agencies can benefit from demand for movement disorder management under specialist supervision. Ropinirole 0.5mg is a dopamine agonist used in neurological care Commonly prescribed for the management of Parkinson’s disease and Restless Legs Syndrome (RLS) as advised by healthcare professionals Helps improve symptoms such as tremors, stiffness, slowed movements, and discomfort associated with movement disorders in appropriate patients Lower-strength formulation is particularly useful for treatment initiation and gradual dose titration according to individual patient requirements Oral tablet formulation provides convenient administration for long-term therapy under medical supervision Requires regular monitoring and individualized dosing by qualified healthcare professionals Frequently utilized in neurology clinics, hospitals, movement disorder centers, and specialty healthcare facilities Widely prescribed by neurologists and CNS specialists This strengthens a comprehensive neurology and Parkinson’s care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ropinirole 0.5mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from specialty healthcare market opportunities, consistent prescription demand, repeat purchases, reliable supply chain support, and attractive margins in the neurology segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.